EUVIMEDEUVIMED entdecken
Übersichtsarbeit

L’hypercholestérolémie familiale en Tunisie

A Jelassi, I Jguirim, M Najah, F Maatouk, K Ben Hamda, M N Slimane

Pathologie Biologie · 2009-07 · 57 (5) · 444-450

DOI: 10.1016/j.patbio.2008.09.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathologie Biologie, 2009-07. Verfasst von A Jelassi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unité de recherche sur les facteurs génétiques et biologiques de l'athérosclérose, laboratoire de biochimie, faculté de médecine de Monastir, 5019 Mo…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Familial hypercholesterolemia or autosomal dominant hypercholesterolemia is characterized by raised serum LDL (low density lipoproteins)-cholesterol levels, which result in excess deposition of cholesterol in tissues, leading to accelerated atherosclerosis and increased risk of premature coronary heart disease. Familial hypercholesterolemia results from defects in the hepatic uptake and degradation of LDL via the LDL receptor pathway. Familial hypercholesterolemia is commonly caused by a loss of function in the LDL receptor gene, or by a mutation in the gene encoding apolipoprotein B (APOB) or PCSK9 gene. In Tunisia, the frequency of this disease is about one of 165 for heterozygote. It is a higher frequency compared to most European countries, which is about one of 500 for heterozygote. Only five mutations in the LDLR gene were reported in this population. No mutations in the APOB or PCSK9 gene were reported.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoproteins BDNA Mutational AnalysisGenes, DominantGenes, RecessiveGenotypeHumansHyperlipoproteinemia Type IIMutationProprotein Convertase 9Proprotein ConvertasesProtein Structure, TertiaryReceptors, LDLSerine EndopeptidasesTunisia

Substanzen

Apolipoproteins BReceptors, LDLPCSK9 protein, humanProprotein Convertase 9Proprotein ConvertasesSerine Endopeptidases

Autor:innen und Institutionen

  • Unité de recherche sur les facteurs génétiques et biologiques de l'athérosclérose, laboratoire de biochimie, faculté de médecine de Monastir, 5019 Monastir, Tunisie.

Zitieren

APA

Jelassi, A., Jguirim, I., Najah, M., Maatouk, F., Ben Hamda, K., & Slimane, M. N. (2009). L’hypercholestérolémie familiale en Tunisie. Pathologie Biologie, 57(5), 444-450. https://doi.org/10.1016/j.patbio.2008.09.015

Vancouver

Jelassi A, Jguirim I, Najah M, Maatouk F, Ben Hamda K, Slimane MN. L’hypercholestérolémie familiale en Tunisie. Pathologie Biologie. 2009;57(5):444-450. doi:10.1016/j.patbio.2008.09.015

BibTeX
@article{Jelassi2009,
  author = {Jelassi, A and Jguirim, I and Najah, M and Maatouk, F and Ben Hamda, K and Slimane, M N},
  title = {L’hypercholestérolémie familiale en Tunisie},
  journal = {Pathologie Biologie},
  year = {2009},
  volume = {57},
  number = {5},
  pages = {444--450},
  doi = {10.1016/j.patbio.2008.09.015}
}
Kostenlos starten →